Occult Cushing's Syndrome in Type-2 Diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 12, 2003, Pages 5808-5813

  Catargi, Bogdan ^a   Rigalleau, Vincent ^a   Poussin, Agathe ^a   Ronci Chaix, Nathalie ^a   Bex, Veronique ^a   Vergnot, Vincent ^a   Gin, Henri ^a   Roger, Patrick ^a   Tabarin, Antoine ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL I 131; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CORTICOTROPIN; DEXAMETHASONE; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; KETOCONAZOLE; NORCHOL 131;

ADRENAL CORTEX ADENOMA; ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; CHEMICAL ANALYSIS; CIRCADIAN RHYTHM; CLINICAL FEATURE; CONTROLLED STUDY; CUSHING DISEASE; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DRUG UPTAKE; FEMALE; HORMONE INHIBITION; HOSPITAL PATIENT; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMAGE ANALYSIS; IMAGING; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; SCINTIGRAPHY; SCREENING; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

AGED; COHORT STUDIES; CUSHING SYNDROME; DEXAMETHASONE; DIABETES MELLITUS, TYPE 2; FEMALE; FRANCE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; MALE; MASS SCREENING; MIDDLE AGED; OBESITY; PREVALENCE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0347362879     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030254     Document Type: Article

References (41)

1. Boscaro M, Barzon L, Fallo F, Sonino N 2001 Cushing's syndrome. Lancet 357:785-791
2. Chidiac RM, Aron DC 1997 Incidentalomas. A disease of modern technology. Endocrinol Metab Clin North Am 26:233-253
3. Tauchmanova L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S, Lombardi G 2002 Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 87:4872-4878
4. Fernandez-Real JM, Engel WR, Simo R, Salinas I, Webb SM 1998 Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma. Clin Endocrinol (Oxf) 49:53-61
5. Garrapa GG, Pantanetti P, Arnaldi G, Mantero F, Faloia E 2001 Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. J Clin Endocrinol Metab 86:5301-5306
6. Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T 2001 The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol (Oxf) 54:797-804
7. Terzolo M, Pia A, Ali A 2002 Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 87:998-1003
8. Angeli A, Terzolo M 2002 Adrenal incidentaloma: a modern disease with old complications. J Clin Endocrinol Metab 87:4869-4871
9. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B 1995 Incidentally discovered adrenal masses. Endocr Rev 16:460-484
10. Leibowitz G, Tsur A, Chayen SD 1996 Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf) 44:717-722
11. Tsagarakis S, Kokkoris P, Roboti C 1998 The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome. Clin Endocrinol (Oxf) 48:627-633
12. Valli N, Catargi B, Ronci N 2001 Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. Eur J Endocrinol 144: 401-408
13. Rossi R, Tauchmanova L, Luciano A 2000 Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85:1440-1448
14. Abou Samra AB, Dechaud H, Estour B 1985 β-lipotropin and cortisol responses to an intravenous infusion dexamethasone suppression test in Cushing's syndrome and obesity. J Clin Endocrinol Metab 61:116-119
15. Newell-Price J, Trainer P, Besser M, Grossman A 1998 The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 19:647-672
16. Perry LA, Grossman AB 1997 The role of the laboratory in the diagnosis of Cushing's syndrome. Ann Clin Biochem 34:345-359
17. Takao T, Mimoto T, Yamamoto M, Hashimoto K 2001 Preclinical Cushing disease. Arch Intern Med 161:892-893
18. Orth D, Kovacs W 1998 The adrenal cortex. In: Williams textbook of endocrinology. Philadelphia: Saunders; 517-664
19. Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M 1995 A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) 43:545-550
20. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W 1992 Preclinical Cushing's syndrome in adrenal incidentalomas: comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 75:826-832
21. Reincke M 2000 Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 29:43-56
22. Ambrosi B, Peverelli S, Passini E 1995 Abnormalities of endocrine function in patients with clinically silent adrenal masses. Eur J Endocrinol 132:422-428
23. Barzon L, Scaroni C, Sonino N 1998 Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab 83:55-62
24. Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N 1998 Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clin Endocrinol (Oxf) 49:165-171
25. Bardet S, Rohmer V, Murat A 1996 131I-6 β-Iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clin Endocrinol (Oxf) 44:587-596
26. Barzon L, Fallo F, Sonino N, Boscaro M 2001 Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas. Eur J Endocrinol 145:223-224
27. Barzon L, Fallo F, Sonino N, Boscaro M 2002 Development of overt Cushing's syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 146:61-66
28. Mantero F, Terzolo M, Arnaldi G 2000 A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637-644
29. Yanovski JA, Cutler Jr GB, Chrousos GP, Nieman LK 1993 Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA 269:2232-2238
30. Cameron OG, Thomas B, Tiongco D, Hariharan M, Greden JF 1987 Hypercortisolism in diabetes mellitus. Diabetes Care 10:662-664
31. Spyer G, Hattersley AT, MacDonald IA, Amiel S, MacLeod KM 2000 Hypoglycaemic counter-regulation at normal blood glucose concentrations in patients with well controlled type-2 diabetes. Lancet 356:1970-1974
32. Bjomtorp P, Holm G, Rosmond R 1999 Hypothalamic arousal, insulin resistance and type-2 diabetes mellitus. Diabet Med 16:373-383
33. Duclos M, Gatta B, Corcuff JB, Rashedi M, Pehourcq F, Roger P 2001 Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary-adrenal axis activity and sensitivity to glucocorticoids. Clin Endocrinol (Oxf) 55:447-454
34. Pasquali R, Cantobelli S, Casimirri F 1993 The hypothalamic-pituitary- adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 77:341-346
35. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ 2001 The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069-1078
36. Crapo L 1979 Cushing's syndrome: a review of diagnostic tests. Metabolism 28:955-977
37. Lavoix H, Lacroix A 1995 Partially autonomous cortisol secretion by incidentally discovered adrenal adenoma. Trends Endocrinol Metab 46:191-197
38. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B 1997 Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome-recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 34:222-229
39. Huizenga NA, Koper JW, de Lange P 1998 Interperson variability but in-traperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. J Clin Endocrinol Metab 83:47-54
40. DeFronzo RA 1999 Pharmacologic therapy for type-2 diabetes mellitus. Ann Intern Med 131:281-303
41. Dinneen S, Alzaid A, Miles J, Rizza R 1993 Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans. J Clin Invest 92:2283-2290